CN111297965A - Traditional Chinese medicine composition for treating chronic nephritis - Google Patents

Traditional Chinese medicine composition for treating chronic nephritis Download PDF

Info

Publication number
CN111297965A
CN111297965A CN202010338478.0A CN202010338478A CN111297965A CN 111297965 A CN111297965 A CN 111297965A CN 202010338478 A CN202010338478 A CN 202010338478A CN 111297965 A CN111297965 A CN 111297965A
Authority
CN
China
Prior art keywords
root
traditional chinese
chinese medicine
medicine composition
chronic nephritis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN202010338478.0A
Other languages
Chinese (zh)
Inventor
艾金长
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ai Jinchang
Peng Guang
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010338478.0A priority Critical patent/CN111297965A/en
Publication of CN111297965A publication Critical patent/CN111297965A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/738—Rosa (rose)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/41—Crassulaceae (Stonecrop family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/74—Rubiaceae (Madder family)
    • A61K36/744—Gardenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating chronic nephritis, which comprises the following raw materials: root of cherokee rose, root of golden gold, root of cape jasmine, snow of june, chrysanthemum flower of Tianbian and Indian damnacanthus. The traditional Chinese medicine composition is suitable for chronic nephritis patients, has no adverse reaction and stable curative effect.

Description

Traditional Chinese medicine composition for treating chronic nephritis
Technical Field
The invention relates to the field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating chronic nephritis.
Background
The chronic glomerulonephritis is called chronic nephritis for short, and refers to a group of glomerulonephritis which takes proteinuria, hematuria, hypertension and edema as basic clinical manifestations, has different onset modes, has persistent disease conditions and slow progression of pathological changes, can reduce renal function to different degrees, and finally develops into chronic renal failure. At present, western medicine has no clear cause, so that the treatment is lack of pertinence and only can be used for symptomatic treatment.
Therefore, there is a need to provide a Chinese medicinal composition for treating chronic nephritis, which can solve the above problems.
Disclosure of Invention
In order to solve the technical problems, the invention provides the traditional Chinese medicine composition for treating chronic nephritis, which is suitable for chronic nephritis patients, has no adverse reaction and stable curative effect.
The invention provides a traditional Chinese medicine composition for resisting lung cancer, which is prepared from the following raw materials: root of cherokee rose, root of golden gold, root of cape jasmine, snow of june, chrysanthemum flower of Tianbian and Indian damnacanthus.
The further scheme is that the feed is prepared from the following raw materials in parts by weight: 10-50 g of cherokee rose root, 10-50 g of golden yellow root, 10-50 g of gardenia root, 20-30 g of serissa serissoide, 20-30 g of chrysanthemum indicum and 20-30 g of Indian damnacanthus herb.
The further scheme is that the feed is prepared from the following raw materials by weight: 10 g of cherokee rose root, 10 g of golden root, 10 g of gardenia root, 20 g of serissa serissoides, 20 g of chrysanthemum indicum and 20 g of Indian damnacanthus herb.
The further scheme is that the feed is prepared from the following raw materials by weight: 30 g of cherokee rose root, 30 g of golden root, 30 g of gardenia root, 25 g of serissa serissoides, 25 g of chrysanthemum indicum and 25 g of Indian damnacanthus herb.
The further scheme is that the feed is prepared from the following raw materials by weight: 50 g of cherokee rose root, 50 g of golden root, 50 g of gardenia root, 30 g of serissa serissoides, 30 g of chrysanthemum indicum and 30 g of Indian damnacanthus herb.
The traditional Chinese medicine composition can be prepared into various applicable formulations such as decoction, powder, pills or capsules.
The invention has the beneficial effects that:
the traditional Chinese medicine composition can clear away heat and toxic materials, tonify qi and kidney, induce diuresis and reduce edema, is suitable for patients with chronic nephritis, has no adverse reaction, and has stable curative effect.
Detailed Description
In order to make the aforementioned objects, features and advantages of the present invention comprehensible, specific embodiments thereof are described in detail below. In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present invention. This invention can be embodied in many different forms than those herein described and many modifications may be made by one skilled in the art without departing from the spirit and scope of the invention.
The present invention will be further described with reference to the following embodiments.
Example 1
Taking the following raw materials by weight: 10 g of cherokee rose root, 10 g of golden root, 10 g of gardenia root, 20 g of serissa serissoides, 20 g of chrysanthemum indicum and 20 g of Indian damnacanthus herb, and the traditional Chinese medicine composition is prepared.
Example 2
Taking the following raw materials by weight: 30 g of cherokee rose root, 30 g of golden root, 30 g of gardenia root, 25 g of serissa serissoides, 25 g of chrysanthemum indicum and 25 g of Indian damnacanthus herb to prepare the traditional Chinese medicine composition.
Example 3
Taking the following raw materials by weight: 50 g of cherokee rose root, 50 g of golden root, 50 g of gardenia root, 30 g of serissa serissoides, 30 g of chrysanthemum indicum and 30 g of Indian damnacanthus herb, and the traditional Chinese medicine composition is prepared.
The Chinese medicinal composition can be prepared into various applicable formulations such as decoction, powder, pills or capsules, and can also be added into drinks.
The traditional Chinese medicine composition comprises the following components:
root of cherokee rose: has mild nature and sour and astringent taste, has the effects of controlling nocturnal emission and astringing intestines, is mainly used for treating spermatorrhea, enuresis, dysentery and diarrhea, metrorrhagia and metrostaxis, hemorrhoids, scalds and the like, also has the effects of benefiting qi and tonifying kidney, and can reduce proteinuria.
The golden root has the effects of clearing away heat and toxic materials, inducing diuresis and relieving swelling, and can be used for treating tympanites and edema.
Gardenia root: has sweet and bitter taste and cold property, has the efficacies of clearing heat, promoting diuresis and reducing edema, and can treat urinary tract infection, nephritis edema, mastitis, toothache due to pathogenic wind-fire, sore and carbuncle, pyogenic infection and traumatic injury.
Serissa japonica has effects of invigorating spleen, promoting diuresis, dispersing stagnated liver qi, and promoting blood circulation, and can be used for treating acute and chronic hepatitis, amenorrhea, leucorrhea, and rheumatic lumbago.
And (3) treating the agrimony: pungent and cool, and has the effects of cooling blood, stopping bleeding, clearing heat, promoting diuresis, removing toxicity and relieving swelling. Can be used for treating wind-heat type common cold, bronchitis, tonsillitis, parotitis, mastitis, hepatitis, enteritis, dysentery, hematemesis, epistaxis, urinary system infection, and epistaxis.
And (3) tiger stabs: bitter and astringent taste, and cool in nature. Clearing away heat and toxic materials, dispelling pathogenic wind, removing dampness, relieving swelling and pain, and can be used for treating cough due to lung heat, swelling and pain of throat, rheumatalgia, toothache, rubella pruritus, skin ulcer, furuncle, and traumatic injury.
In the composition, the cherokee rose root, the golden root and the gardenia root are compatible to clear away heat and toxic materials, tonify the kidney and replenish qi, induce diuresis and relieve swelling are used together as monarch, serissa serissoides invigorates the spleen, induces diuresis and relieves swelling, earthy water is used as minister, and the lopsideum and the Indian damnacanthus herb are used as assistant to clear away heat, toxic materials and relieve swelling. The medicines are used together to clear away heat and toxic material, tonify qi and kidney, induce diuresis and reduce edema.
The Chinese medicinal composition can achieve the effects of clearing heat and removing toxicity, tonifying qi and kidney, and inducing diuresis to reduce edema.
The traditional Chinese medicine composition has scientific and reasonable components and safe compatibility and medication, 100 cases of clinical observation data of patients are provided by screening in order to show the treatment effect of the traditional Chinese medicine composition, the 100 cases are divided into two groups according to the random distribution principle, the two groups of patients are respectively 52 cases of treatment groups and 48 cases of comparison groups, the difference of the two groups of patients is not statistically significant in comparison of the disease conditions, the personal basic conditions and the like, and the two groups of patients have comparability.
Firstly, selecting a standard:
patients with chronic nephritis can be used as a standard for selecting cases.
II, diagnosis standard:
edema, hematuria, dry and bitter mouth, lassitude, sticky stool, red tongue with yellow and greasy coating, and slippery and rapid pulse.
Third, embodiment
The treatment group uses the traditional Chinese medicine composition to prepare decoction according to requirements, the decoction is taken once in the morning and at night, each time is 300 ml, 1 month is a treatment course, and statistics is carried out after 1 treatment course.
The control group is orally administered according to the prescription of the medicine, 1 month is a treatment course, and statistics is carried out after 1 treatment course.
Fourth, comparison results
In the treatment group, 30 patients improved, accounting for 57.7 percent, 12 patients with the disease being effective accounting for 23.1 percent, 9 patients with the disease being ineffective accounting for 17.3 percent, and the total effective rate accounting for 80.8 percent; in the control group, 17 patients improved, accounting for 35.4%, 12 patients with effective patients accounting for 25%, 19 patients with ineffective patients accounting for 39% and the total effective rate accounting for 60.4%; the improvement of the disease condition means that the self feeling of the patient, the diagnosis by medical instruments and the diagnosis result of the traditional Chinese medicine are all reduced compared with the result before treatment, the effective condition means that the disease condition of the patient is controlled, and the ineffective condition means ineffective symptom and no obvious improvement.
The observation result shows that the traditional Chinese medicine composition has good treatment effect on chronic nephritis patients.
The traditional Chinese medicine composition is prepared into other dosage forms, the same or similar results are obtained in experiments, the listing is omitted, the description is prevented from being accumulated, and the application claims the traditional Chinese medicine composition (combination invention) rather than the dosage form or the preparation method, so that any dosage form prepared from the traditional Chinese medicine composition belongs to the protection scope of the application and medicines for treating the same diseases.

Claims (6)

1. A traditional Chinese medicine composition for treating chronic nephritis comprises the following raw materials: root of cherokee rose, root of golden gold, root of cape jasmine, snow of june, chrysanthemum flower of Tianbian and Indian damnacanthus.
2. The traditional Chinese medicine composition for treating chronic nephritis according to claim 1, is characterized by comprising the following raw materials in parts by weight: the feed is prepared from the following raw materials in parts by weight: 10-50 g of cherokee rose root, 10-50 g of golden yellow root, 10-50 g of gardenia root, 20-30 g of serissa serissoide, 20-30 g of chrysanthemum indicum and 20-30 g of Indian damnacanthus herb.
3. The traditional Chinese medicine composition for treating chronic nephritis according to claim 2, is characterized by being prepared from the following raw materials by weight: 10 g of cherokee rose root, 10 g of golden root, 10 g of gardenia root, 20 g of serissa serissoides, 20 g of chrysanthemum indicum and 20 g of Indian damnacanthus herb.
4. The traditional Chinese medicine composition for treating chronic nephritis according to claim 2, is characterized by being prepared from the following raw materials by weight: 30 g of cherokee rose root, 30 g of golden root, 30 g of gardenia root, 25 g of serissa serissoides, 25 g of chrysanthemum indicum and 25 g of Indian damnacanthus herb.
5. The traditional Chinese medicine composition for treating chronic nephritis according to claim 2, is characterized by being prepared from the following raw materials by weight: 50 g of cherokee rose root, 50 g of golden root, 50 g of gardenia root, 30 g of serissa serissoides, 30 g of chrysanthemum indicum and 30 g of Indian damnacanthus herb.
6. The Chinese medicinal composition for treating chronic nephritis according to any of claims 1-5, wherein: the Chinese medicinal composition is prepared into decoction, powder, pills or capsules.
CN202010338478.0A 2020-04-26 2020-04-26 Traditional Chinese medicine composition for treating chronic nephritis Withdrawn CN111297965A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010338478.0A CN111297965A (en) 2020-04-26 2020-04-26 Traditional Chinese medicine composition for treating chronic nephritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010338478.0A CN111297965A (en) 2020-04-26 2020-04-26 Traditional Chinese medicine composition for treating chronic nephritis

Publications (1)

Publication Number Publication Date
CN111297965A true CN111297965A (en) 2020-06-19

Family

ID=71154175

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010338478.0A Withdrawn CN111297965A (en) 2020-04-26 2020-04-26 Traditional Chinese medicine composition for treating chronic nephritis

Country Status (1)

Country Link
CN (1) CN111297965A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112107635A (en) * 2020-10-14 2020-12-22 艾金长 Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion
CN112107654A (en) * 2020-10-14 2020-12-22 艾金长 Traditional Chinese medicine composition for treating cervical spondylosis

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110974887A (en) * 2020-01-22 2020-04-10 艾金长 Traditional Chinese medicine composition for resisting lung cancer
CN111298043A (en) * 2020-04-26 2020-06-19 艾金长 Traditional Chinese medicine composition for treating type 2 diabetes
CN112107654A (en) * 2020-10-14 2020-12-22 艾金长 Traditional Chinese medicine composition for treating cervical spondylosis
CN112107635A (en) * 2020-10-14 2020-12-22 艾金长 Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110974887A (en) * 2020-01-22 2020-04-10 艾金长 Traditional Chinese medicine composition for resisting lung cancer
CN111298043A (en) * 2020-04-26 2020-06-19 艾金长 Traditional Chinese medicine composition for treating type 2 diabetes
CN112107654A (en) * 2020-10-14 2020-12-22 艾金长 Traditional Chinese medicine composition for treating cervical spondylosis
CN112107635A (en) * 2020-10-14 2020-12-22 艾金长 Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112107635A (en) * 2020-10-14 2020-12-22 艾金长 Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion
CN112107654A (en) * 2020-10-14 2020-12-22 艾金长 Traditional Chinese medicine composition for treating cervical spondylosis

Similar Documents

Publication Publication Date Title
CN101569739B (en) Traditional Chinese medicine composition for treating cholecystitis and preparation method thereof
CN110974887A (en) Traditional Chinese medicine composition for resisting lung cancer
CN111297965A (en) Traditional Chinese medicine composition for treating chronic nephritis
CN101596252B (en) Composition for treating herpes zoster and preparation method thereof
CN101396528B (en) Traditional Chinese medicine composite preparation for treating wind-heat cold
CN104997860A (en) Traditional Chinese medicine preparation for treating duodenal ulcer and preparation method thereof
CN102580142B (en) Chinese medicinal liniment for postoperative healing of orthopaedic surgery and preparation method
CN111407808B (en) Traditional Chinese medicine composition and preparation method and pharmaceutical application thereof
CN1132587C (en) Preparation method of medicine for curing surgical diseases of traditional Chinese medicine
CN105055657A (en) Spraying agent for improving pain caused by wisdom teeth and preparation method thereof
CN115737748B (en) External application medicine for treating scrofula
CN115120690B (en) Traditional Chinese medicine composition for treating precocious puberty and application thereof
CN108704105A (en) A kind of Chinese medicine composition for treating Acute Cerebral Infarction
CN1054052C (en) Comedo-elimination preparation
CN102626491B (en) Externally used Traditional Chinese medicine composition for treatment of lumbar interveterbral disc protrusion
CN115252732B (en) Traditional Chinese medicine composition for clearing lung and relieving cough and application thereof
CN114159536B (en) Pharmaceutical composition, preparation method and application thereof
CN105412244A (en) Traditional Chinese medicine composition treating gynecological cervicitis
CN104998189A (en) Traditional Chinese medicine powder for treating infantile oral ulcer of wind-heat spleen type and preparation method thereof
CN104906352A (en) Traditional Chinese medicine liquid for treating deficiency-fire flaring-up type infantile oral ulcer and preparation method thereof
CN105477246A (en) Traditional Chinese medicine composition for treating phlegmatic hygrosis type mammary gland hyperplasia and preparation method thereof
CN104984147A (en) Traditional Chinese medicinal tablet for treating infant scalp folliculitis, and preparation method thereof
CN115137775A (en) Preparation for treating psoriasis caused by stagnated heat in liver channel and preparation method and application thereof
CN103784706A (en) Medicine composition for treating intestinal tympany of equus animals
CN116115714A (en) Anti-tumor traditional Chinese medicine composition and preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20210809

Address after: 414000 Yueyang traditional Chinese medicine hospital, fengqiaohu Road, Yueyanglou District, Yueyang City, Hunan Province

Applicant after: Ai Jinchang

Applicant after: Peng Guang

Address before: 414000 Yueyang traditional Chinese medicine hospital, fengqiaohu Road, Yueyanglou District, Yueyang City, Hunan Province

Applicant before: Ai Jinchang

WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20200619